Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Pharmacogenet Genomics. 2010 Feb;20(2):86–93. doi: 10.1097/FPC.0b013e32833428d0

Table 5.

This table shows the area under the receiver operating characteristic curve for the Combined Clinical and Pharmacogenetic Test in each clinical trial if we predict the lowest 10th, 20th, or 30th percentile of bronchodilator response

Ft CAMP LODO Asthma Trial
10th percentile of BDR 0.62 0.70 0.62
20th percentile of BDR 0.65 0.63 0.60
30th percentile of BDR 0.65 0.64 0.62

AUROC, area under the receiver operating characteristic curves; BDR, bronchodilator response; CAMP, Childhood Asthma Management Program; LODO, Effectiveness of Low Dose Theophylline as Add-on Treatment in Asthma Trial.